MARKET

BBNX

BBNX

Beta Bionics, Inc.
NASDAQ
9.46
+0.26
+2.83%
After Hours: 9.64 +0.18 +1.90% 19:33 05/15 EDT
OPEN
9.03
PREV CLOSE
9.20
HIGH
9.47
LOW
9.01
VOLUME
906.25K
TURNOVER
--
52 WEEK HIGH
32.71
52 WEEK LOW
8.80
MARKET CAP
421.55M
P/E (TTM)
-6.2587
1D
5D
1M
3M
1Y
5Y
1D
Insulet: An Opportune Time To Get Involved
Seeking Alpha · 2d ago
Weekly Report: what happened at BBNX last week (0504-0508)?
Weekly Report · 4d ago
First Eagle Small Cap Opportunity Fund Q1 2026 Portfolio Review
Seeking Alpha · 05/06 17:23
Weekly Report: what happened at BBNX last week (0427-0501)?
Weekly Report · 05/04 09:35
Beta Bionics to present at Bank of America Securities Health Care Conference
PUBT · 04/27 20:26
Weekly Report: what happened at BBNX last week (0420-0424)?
Weekly Report · 04/27 09:36
Beta Bionics Earnings Call Highlights Growth And Risks
TipRanks · 04/23 00:33
Beta Bionics Is Maintained at Outperform by Leerink Partners
Dow Jones · 04/22 14:01
More
About BBNX
Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development and commercialization of various solutions to improve the health of insulin-requiring people with diabetes (PWD). The Company's product, the iLet Bionic Pancreas (iLet), is an insulin delivery device cleared by the United States Food and Drug Administration (FDA) to utilize adaptive closed-loop algorithms to autonomously determine every insulin dose without requiring a user to count carbohydrate intake. iLet is used for the treatment of Type 1 diabetes (T1D). The Company's solutions include iLet for Adults, iLet for Children, Bionic Circle App and iLet Simulator. The Company is in the early stages of developing an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing, commonly known in the diabetes industry as a patch pump. It is also in the early stages of developing a bihormonal configuration of the iLet.

Webull offers Beta Bionics, Inc. stock information, including NASDAQ: BBNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BBNX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BBNX stock methods without spending real money on the virtual paper trading platform.